Special Issue "Nucleic Acid-based Drug"
Deadline for manuscript submissions: closed (30 July 2016)
RNA Therapeutics is an innovative strategy and a new molecular entity with the potential to to treat a wide variety of diseases. Research and development in oligonucleotide-based drugs have grown tremendously over the past decade. This Special Issue, "Nucleic Acid-based Drug", will cover different aspects of RNA drug discovery and development from chemical synthesis and modifications of antisense oligonucleotide (ASO), small interfering RNA (siRNA), anti-microRNA (anti-miRNA) and steric-blocking oligonucleotides, delivery systems to enhance cellular penetration, and pre-clinical and clinical studies of RNA therapeutics in the treatment of genetic diseases, cancers, metabolic diseases, cardiovascular diseases, lung diseases, wound healing, and infectious diseases.
Prof. Dr. Wai Shiu Fred Wong
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Antisense oligonucleotide (ASO)
- small interfering RNA (siRNA)
- chemical modifications
- delivery systems
- RNA therapeutics